US grants iPS cell patent to Japanese university pioneer
This article was originally published in Clinica
Kyoto University has been issued a US patent relating to induced pluripotent stem (iPS) cell technology, in a decision which should help pave the way to the eventual development of regenerative therapies for various disorders.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.